Improving inhaler use in COPD and the role of patient preference

Chronic obstructive pulmonary disease (COPD) is a difficult disease to manage, but recent research focusing on its pathophysiology has provided direction for the development of new treatments and improved management strategies. COPD differs substantially from asthma, both in its pathophysiology and...

Full description

Bibliographic Details
Main Author: E. D. Bateman
Format: Article
Language:English
Published: European Respiratory Society 2005-12-01
Series:European Respiratory Review
Subjects:
Online Access:http://err.ersjournals.com/cgi/content/full/14/96/85
_version_ 1818060212618133504
author E. D. Bateman
author_facet E. D. Bateman
author_sort E. D. Bateman
collection DOAJ
description Chronic obstructive pulmonary disease (COPD) is a difficult disease to manage, but recent research focusing on its pathophysiology has provided direction for the development of new treatments and improved management strategies. COPD differs substantially from asthma, both in its pathophysiology and its treatment. Unlike asthma, COPD cannot be fully controlled or "reversed"; it is progressive and responses to anti-inflammatory drugs, including corticosteroids, have been disappointing, suggesting the presence of a unique, persistent form of inflammation. The current main emphasis in the treatment of COPD is therefore to minimise airflow obstruction using regular bronchodilator therapy. Apparently small improvements in traditional measures of airflow obstruction, such as functional residual capacity, may produce significant improvements in other measures, resulting in clinical benefit. Ensuring efficient delivery of bronchodilators is vital to treatment success but has received little attention in guidelines to date. Inhaler technique, adherence rates and levels of satisfaction with therapy are all far from ideal. Improvements in these areas require more detailed consideration of the interactions between the patient, the healthcare provider and the inhaler device, and an examination of how inhaler choices are currently made by both healthcare provider and patient.
first_indexed 2024-12-10T13:28:50Z
format Article
id doaj.art-0bc363c67e9c48178962befe7895000f
institution Directory Open Access Journal
issn 0905-9180
1600-0617
language English
last_indexed 2024-12-10T13:28:50Z
publishDate 2005-12-01
publisher European Respiratory Society
record_format Article
series European Respiratory Review
spelling doaj.art-0bc363c67e9c48178962befe7895000f2022-12-22T01:47:03ZengEuropean Respiratory SocietyEuropean Respiratory Review0905-91801600-06172005-12-0114968588Improving inhaler use in COPD and the role of patient preferenceE. D. BatemanChronic obstructive pulmonary disease (COPD) is a difficult disease to manage, but recent research focusing on its pathophysiology has provided direction for the development of new treatments and improved management strategies. COPD differs substantially from asthma, both in its pathophysiology and its treatment. Unlike asthma, COPD cannot be fully controlled or "reversed"; it is progressive and responses to anti-inflammatory drugs, including corticosteroids, have been disappointing, suggesting the presence of a unique, persistent form of inflammation. The current main emphasis in the treatment of COPD is therefore to minimise airflow obstruction using regular bronchodilator therapy. Apparently small improvements in traditional measures of airflow obstruction, such as functional residual capacity, may produce significant improvements in other measures, resulting in clinical benefit. Ensuring efficient delivery of bronchodilators is vital to treatment success but has received little attention in guidelines to date. Inhaler technique, adherence rates and levels of satisfaction with therapy are all far from ideal. Improvements in these areas require more detailed consideration of the interactions between the patient, the healthcare provider and the inhaler device, and an examination of how inhaler choices are currently made by both healthcare provider and patient.http://err.ersjournals.com/cgi/content/full/14/96/85Chronic obstructive pulmonary diseaseinhalation devicespatient preference
spellingShingle E. D. Bateman
Improving inhaler use in COPD and the role of patient preference
European Respiratory Review
Chronic obstructive pulmonary disease
inhalation devices
patient preference
title Improving inhaler use in COPD and the role of patient preference
title_full Improving inhaler use in COPD and the role of patient preference
title_fullStr Improving inhaler use in COPD and the role of patient preference
title_full_unstemmed Improving inhaler use in COPD and the role of patient preference
title_short Improving inhaler use in COPD and the role of patient preference
title_sort improving inhaler use in copd and the role of patient preference
topic Chronic obstructive pulmonary disease
inhalation devices
patient preference
url http://err.ersjournals.com/cgi/content/full/14/96/85
work_keys_str_mv AT edbateman improvinginhaleruseincopdandtheroleofpatientpreference